This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Gary Ritchie
Advertisement
Gary Ritchie, InfraTrac gritchie@infratrac.com, is director of Scientific Affairs at InfraTrac.
Articles by Gary Ritchie
Advertisement
Latest Updated Articles
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding ApplicationsPublished: December 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
4
AAPS PharmSci 360 2025: Trends in Bioanalysis
5
